These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 219616)

  • 1. [Change in the level of immunoglobulins A in the intestines of children after administration of live trivalent poliomyelitis vaccine by different methods].
    Shmel'kov IuA
    Vopr Virusol; 1978; (4):434-8. PubMed ID: 219616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of various methods of administration of live poliovirus vaccine on the immunoglobulin levels in the blood serum and mouth mucosa secretion in children].
    Shmel'kov IuA; Zhevandrova VI; Kodkind GKh; Drozdov SG; Alpatova GA
    Vopr Virusol; 1978; (1):89-94. PubMed ID: 645061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of secretory and serum immunoglobulins in children in the course of vaccinations with live poliomyelitis monovaccines].
    Shmel'kov IuA; Zhevandrova VI; Drozdov SG
    Vopr Virusol; 1978; (3):332-6. PubMed ID: 358597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
    Drozdov SG; Zhevandrova VI; Smirnova GA; Shmel'kov IuA; Kodkind GKh
    Vopr Virusol; 1979; (3):252-9. PubMed ID: 223328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
    Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
    J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monovalent type 1 oral poliovirus vaccine in newborns.
    el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
    N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulins level in saliva of children with poliomyelitis and of healthy children after oral vaccination with live attenuated poliovirus strains type 2 and 3.
    Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
    Pol Med J; 1970; 9(5):1168-72. PubMed ID: 4101723
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on a single-dose capsule preparation of Poliomyelitis vaccine.
    Barnes JM; Galbraith NS
    Bull World Health Organ; 1966; 34(5):693-9. PubMed ID: 5296232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine.
    Gary HE; Freeman C; Peñaranda S; Maher K; Anderson L; Pallansch MA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S264-7. PubMed ID: 9203727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on poliovirus coproantibody. II. Characterization of neutralizing substance in fecal extracts.
    Kono R; Ikawa S; Yaoi H; Hamada C; Ashihara Y; Kawakami K
    Am J Epidemiol; 1966 Jan; 83(1):14-23. PubMed ID: 5325751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
    Albano A; De Donato S; Scarinci V; Jakschik M
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.